Gastric metastasis of invasive lobular breast cancer, misdiagnosed as primary gastric cancer: a case report and literature review
Breast Communications · 2025
DOI: 10.21037/bc-25-6 ↗Kurz gefasst
Fallbericht in der Zeitschrift Breast Communications, 2025. Verfasst von Xianan Guo und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Breast cancer is the most common cancer diagnosed in women, but gastric metastasis of breast cancer rarely occurs. This article presents an uncommon case of a patient with confirmed gastric metastasis from primary breast cancer who presented with rapid disease progression and a review of differentiation markers and tools. Diffuse liver metastases, a key feature of visceral crisis, often necessitate chemotherapy; however, severe hepatic dysfunction can contraindicate such treatment. The challenge of selecting an appropriate treatment plan in the presence of both conditions has long been a concern for clinicians. Therefore, this article also provides an overview of related studies of treatment options in visceral crisis. Case Description: We present a case of a 54-year-old woman with a history of breast cancer, who was diagnosed with invasive ductal carcinoma 7 years ago and underwent surgery, adjuvant chemotherapy and adjuvant endocrine therapy. Following the first recurrence of axillary lymph node metastasis, the patient received additional chemotherapy, radiotherapy and endocrine therapy. When a gastric lesion was detected in the patient, the patient was initially diagnosed with primary gastric cancer based on endoscopy findings, but further immunohistochemical (IHC) evaluation revealed that the gastric malignancy was actually a metastasis from breast cancer. Upon recurrence, the patient experienced rapid multi-organ metastases with a significant tumor burden and severe hepatic dysfunction. After a multidisciplinary team discussion, the experts held the opinion that both chemotherapy (a less aggressive regimen) and endocrine therapy (cyclin-dependent kinase 4/6 inhibitors combined with fulvestrant) are viable options. The patient chose to be treated with chemotherapy (170 mg nab-paclitaxel). Unfortunately, chemotherapy was administered only once because of the presence of grade-4 myelosuppression and gut-derived septic shock, and the patient passed away 2 months after the relapse.
Conclusions
This case highlights the importance of considering metastatic gastric cancer when a new stomach lesion is observed in patients previously diagnosed with a a breast tumor. Histopathological examinations, especially disease-specific IHC analysis, are crucial for an accurate diagnosis and subsequent treatment. Moreover, chemotherapy is not the sole therapeutic option for breast cancer patients experiencing a visceral crisis.
Zitieren
APA
Guo, X., Chen, H., Zhou, Y., Li, P., & Chen, Y. (2025). Gastric metastasis of invasive lobular breast cancer, misdiagnosed as primary gastric cancer: a case report and literature review. Breast Communications. https://doi.org/10.21037/bc-25-6
Vancouver
Guo X, Chen H, Zhou Y, Li P, Chen Y. Gastric metastasis of invasive lobular breast cancer, misdiagnosed as primary gastric cancer: a case report and literature review. Breast Communications. 2025. doi:10.21037/bc-25-6
BibTeX
@article{Guo2025,
author = {Guo, Xianan and Chen, Huihui and Zhou, Yunxiang and Li, Panni and Chen, Yiding},
title = {Gastric metastasis of invasive lobular breast cancer, misdiagnosed as primary gastric cancer: a case report and literature review},
journal = {Breast Communications},
year = {2025},
doi = {10.21037/bc-25-6}
}
EUVIMED